International Flavors & Fragrances Inc. (IFF), based in New York, is a prominent global ingredients and specialty-solutions company valued at a market cap of $16.7 billion. The company specializes in formulating sensory and functional solutions that enhance taste, smell, texture, and nutrition in a wide range of everyday products.
As a large-cap stock with a market cap exceeding $10 billion, IFF holds a significant position within the specialty chemicals industry. With a diverse customer base and a global research and development network, the company plays a pivotal role in helping leading brands create differentiated and consumer-preferred products.
Despite experiencing a decline of 27.9% from its 52-week high of $90.64 reached on Dec. 9, 2024, IFF has outperformed the State Street Materials Select Sector ETF (XLB) by dropping only 1.2% over the past three months. However, over the longer term, IFF has fallen 26.5% in the past 52 weeks, trailing behind XLB’s 5.3% loss over the same period. On a year-to-date basis, IFF’s shares are down 22.7%, compared to XLB’s 3.4% return.
In terms of technical analysis, IFF has been trading above its 50-day moving average since early November but remains below its 200-day moving average over the past year.
On Nov. 4, IFF reported better-than-expected third-quarter results, leading to a 4.1% surge in its shares in the following trading session. Despite a 7.9% year-over-year decline in net sales to $2.7 billion, the company exceeded analyst expectations by 2.3%. IFF’s productivity and cost-efficiency initiatives drove solid margin expansion, offsetting lower sales. Consequently, the company’s adjusted earnings per share rose nearly 1% from the prior-year quarter to $1.05, surpassing consensus estimates by 2.9%.
In comparison to its competitor, Ecolab Inc. (ECL), IFF has significantly underperformed, with ECL gaining 3.4% over the past 52 weeks and 10% on a year-to-date basis.
Despite its recent outperformance, analysts maintain a moderately optimistic outlook on IFF’s prospects, giving the stock a consensus rating of “Moderate Buy” from the 20 analysts covering it. The mean price target of $80.61 suggests a 22.8% premium to its current price levels.
Please note that on the date of publication, Neharika Jain did not have any positions in the securities mentioned in this article. All information provided is for informational purposes only. This article was originally published on Barchart.com.
